IP Library Granted Patent US 8,741,620
Granted Patent B2
US 8,741,620 · App. 13/555,243 · Granted Jun 3, 2014

Human lysosomal proteins from plant cell culture

Inventors: Yoseph Shaaltiel (Kibbutz HaSolelim, IL); Gideon Baum (Kibbutz Ayelet HaShachar, IL); Daniel Bartfeld (Kibbutz Moran, IL); Sharon Hashmueli (Ramot-Naftali, IL); Ayala Lewkowicz (Kfar-Vradim, IL)
Assignee: Protalix Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,741,620
App. No.
13/555,243
Granted
Jun 3, 2014
Kind
B2
Abstract

A device, system and method for producing glycosylated proteins in plant culture, particularly proteins having a high mannose glycosylation, while targeting such proteins with an ER signal and/or by-passing the Golgi. The invention further relates to vectors and methods for expression and production of enzymatically active high mannose lysosomal enzymes using transgenic plant root, particularly carrot cells. More particularly, the invention relates to host cells, particularly transgenic suspended carrot cells, vectors and methods for high yield expression and production of biologically active high mannose Glucocerebrosidase (GCD). The invention further provides for compositions and methods for the treatment of lysosomal storage diseases.

Claims (6)

1. A recombinant human glucocerebrosidase protein which comprises the amino acid sequence consisting of human glucocerebrosidase linked at its C terminus to the vacuolar targeting signal peptide as set forth in SEQ ID NO: 2, and wherein said human glucocerebrosidase protein is glycosylated and comprises at least one exposed mannose, at least one fucose having an alpha (1-3) glycosidic bond and at least one xylose.

2. The recombinant human glucocerebrosidase protein of claim 1 , wherein said amino acid sequence of human glucocerebrosidase is as set forth in SEQ ID NO: 8.

3. The recombinant human glucocerebrosidase protein of claim 1 , wherein said human glucocerebrosidase protein is linked at its N terminus to an endoplasmic reticulum signal peptide.

4. The recombinant human glucocerebrosidase protein of claim 1 having glucocerebrosidase catalytic activity.

5. The recombinant human glucocerebrosidase protein of claim 1 , wherein said glucocerebrosidase protein is an isolated protein.

6. A pharmaceutical composition comprising the recombinant human glucocerebrosidase protein of claim 1 and a pharmaceutically acceptable carrier.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Sep 6, 2024
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
To: PROTALIX LTD.
Reel/Frame 068856/0589 →
SECURITY INTEREST Recorded Sep 3, 2021
From: PROTALIX LTD.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 057383/0155 →
SECURITY INTEREST Recorded Dec 12, 2016
From: PROTALIX LTD.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 040708/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2012
From: SHAALTIEL, YOSEPH; BAUM, GIDEON; BARTFELD, DANIEL; HASHMUELI, SHARON; LEWKOWICZ, AYALA
To: PROTALIX LTD.
Reel/Frame 028680/0316 →
Priority Claims (1)
IL 155588 · Apr 27, 2003 · national
Continuity (4)
Division 13080692 · Apr 6, 2011
Division 11790991 · Apr 30, 2007
Continuation In Part 10554387
Related Publication 20120282231A1 · Nov 8, 2012